Company Filing History:
2 out of 56 
1 out of 832,761 Years Active: 2004-2025
Title: Thomas M Snyder: Innovator in T Cell Receptor Research
Introduction
Thomas M Snyder is a notable inventor based in San Bruno, CA (US). He has made significant contributions to the field of immunology, particularly in the development of methods related to T cell receptors. With a total of 3 patents, his work has implications for diagnosing and treating diseases such as Lyme disease and COVID-19.
Latest Patents
One of his latest patents focuses on Lyme disease-associated T cell receptor-related methods. This patent provides methods for assessing T cell receptor β chain complementary determining region 3 (TCRβ CDR3) sequences. The methods involve evaluating TCRβ CDR3 sequences from samples obtained from subjects who have or are suspected of having a tick bite. This assessment can occur even when the subject is seronegative for Lyme disease and may exhibit non-specific symptoms consistent with the disease. Additionally, the patent outlines methods for administering Lyme disease therapy to subjects identified as having T cells that express specific TCRβ CDR3 sequences.
Another significant patent addresses T cell receptor sequences diagnostic for COVID-19. This patent describes methods for assessing biological samples to detect T cells expressing specific TCRβ CDR3 sequences. The presence of these TCRs can help identify individuals with COVID-19 and may assist in prognosticating the severity of the disease. Treatment methods may include administering engineered T cells that express the identified TCRs.
Career Highlights
Throughout his career, Thomas M Snyder has worked with various organizations, including Adaptive Biotechnologies Corporation. His innovative research has positioned him as a key figure in the field of immunology, particularly in the context of infectious diseases.
Collaborations
Thomas has collaborated with notable individuals in his field, including Harlan Saul Robins and Mark Klinger. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Thomas M Snyder's contributions to T cell receptor research have the potential to significantly impact the diagnosis and treatment of diseases like Lyme disease and COVID-19. His innovative methods and collaborations highlight the importance of continued research in immunology.